Statistics

Total Visits

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer84

Select a period of time:

Number of views in the range

Views
Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer22

Views

Views
October 20252
November 20259
December 20256
January 20262
February 20260
March 20261
April 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
United Kingdom3
Brazil3
Germany2
Argentina1
Colombia1
Egypt1
Libya1
 

Top cities views

Views
San Jose2
Frankfurt am Main2
Ashburn1
Bugalagrande1
Giza1
Icaraíma1
Olinda1
Quilmes1
Rorainópolis Municipality1